Molecular Mismatch Predicts T Cell–Mediated Rejection and De Novo Donor‐Specific Antibody Formation After Living Donor Liver Transplantation
Kosuke Ono, Kentaro Ide, Yuka Tanaka, Masahiro Ohira, Hiroyuki Tahara, Naoki Tanimine, Hiroaki Yamane, Hideki Ohdan – 25 July 2021 – Human leukocyte antigen (HLA) molecular mismatch (MM) analysis improves the prediction of clinical outcomes in kidney transplantation compared with prediction via traditional antigen MM. However, it remains unclear whether the level of MM can be used for risk stratification among liver transplantation (LT) recipients.